Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
15.82
-0.31 (-1.92%)
Feb 28, 2025, 2:45 PM CST
SHE:000766 Revenue
In the year 2023, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had annual revenue of 1.47B CNY with 0.18% growth. Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had revenue of 319.41M in the quarter ending September 30, 2024, with 1.16% growth.
Revenue
1.47B
Revenue Growth
+0.18%
P/S Ratio
10.60
Revenue / Employee
868.72K
Employees
1,696
Market Cap
15.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.47B | 2.60M | 0.18% |
Dec 31, 2022 | 1.47B | -44.73M | -2.95% |
Jan 1, 2022 | 1.52B | 403.68M | 36.31% |
Dec 31, 2020 | 1.11B | -865.40M | -43.77% |
Dec 31, 2019 | 1.98B | -117.34M | -5.60% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.93B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Sichuan Biokin Pharmaceutical | 5.85B |